| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | T J Walsh | |
| A J De Lucca | |||
| P2860 | cites work | Identification of the bactericidal domain of lactoferrin | Q24306897 |
| Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity | Q24556650 | ||
| Primary structures of three human neutrophil defensins | Q24563841 | ||
| Defensins. Natural peptide antibiotics of human neutrophils | Q24563852 | ||
| Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor | Q24569680 | ||
| Solution structure of gamma 1-H and gamma 1-P thionins from barley and wheat endosperm determined by 1H-NMR: a structural motif common to toxic arthropod proteins | Q27732015 | ||
| Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene | Q27933785 | ||
| A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons | Q27976520 | ||
| Defensins: antimicrobial and cytotoxic peptides of mammalian cells | Q28268268 | ||
| Structure, function, and membrane integration of defensins | Q28270856 | ||
| Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination | Q28303444 | ||
| Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo | Q28316948 | ||
| In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin | Q28316952 | ||
| Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats | Q28316967 | ||
| Preparation and structure-activity relationships of simplified analogues of the antifungal agent cilofungin: a total synthesis approach | Q28318267 | ||
| Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP) | Q28324452 | ||
| Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors | Q28331119 | ||
| FR900403, a new antifungal antibiotic produced by a Kernia sp | Q28331369 | ||
| Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis | Q28333673 | ||
| Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity | Q28360238 | ||
| Synergistic activity of rabbit granulocyte peptides against Candida albicans | Q28361701 | ||
| In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373 | Q28367886 | ||
| Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis | Q28367890 | ||
| Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro | Q28369533 | ||
| Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin | Q28371536 | ||
| In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates | Q28378977 | ||
| Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans | Q28379123 | ||
| Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis | Q28379219 | ||
| Fungicidal activity of cecropin A | Q28379473 | ||
| In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species | Q28379527 | ||
| In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae | Q28379609 | ||
| A New Family of Plant Antifungal Proteins | Q31136035 | ||
| Deoxymulundocandin-A new echinocandin type antifungal antibiotic | Q33225783 | ||
| Adhesion of Candida albicans to epithelial cells effect of polyoxin D | Q33284306 | ||
| Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes | Q33631782 | ||
| Antibiotics that inhibit fungal cell wall development | Q34059193 | ||
| Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. | Q34104541 | ||
| Cell-free immunity in insects | Q34174010 | ||
| The biological significance of lactoferrin | Q34256491 | ||
| Magainins and the disruption of membrane-linked free-energy transduction | Q34300587 | ||
| Expression of antibiotic resistance genes in the integrated cassettes of integrons | Q34307018 | ||
| Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. | Q34314919 | ||
| Preliminary experimental anticancer activity of cecropins | Q34318107 | ||
| Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins | Q34351505 | ||
| Antifungal agents: chemotherapeutic targets and immunologic strategies | Q34400044 | ||
| Cyclopeptide alkaloids | Q34423531 | ||
| Lipopeptide inhibitors of fungal glucan synthase | Q34425782 | ||
| Site-specific insertion of genes into integrons: role of the 59-base element and determination of the recombination cross-over point | Q34515649 | ||
| The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. | Q40825150 | ||
| Gene cassettes: a new class of mobile element | Q40953370 | ||
| Molecular recognition between membrane-spanning polypeptides | Q40956753 | ||
| Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast Spheroplasts | Q41078788 | ||
| A potent antimicrobial protein from onion seeds showing sequence homology to plant lipid transfer proteins | Q41292557 | ||
| Helioferins; novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structures and biological properties | Q41377072 | ||
| Origins of the mobile gene cassettes found in integrons | Q41627229 | ||
| Sequence and specificity of two antibacterial proteins involved in insect immunity | Q42077306 | ||
| Transport and hydrolysis of peptides in Saccharomyces cerevisiae | Q42217319 | ||
| Mechanism of action of nikkomycin and the peptide transport system of Candida albicans | Q42225118 | ||
| WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties. | Q42282451 | ||
| The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. | Q42282922 | ||
| Structure, synthesis, and activity of dermaseptin b, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin | Q42285997 | ||
| Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1. | Q42539769 | ||
| On the evolution of Tn21-like multiresistance transposons: sequence analysis of the gene (aacC1) for gentamicin acetyltransferase-3-I(AAC(3)-I), another member of the Tn21-based expression cassette | Q42641992 | ||
| Plasmid evolution by acquisition of mobile gene cassettes: plasmid pIE723 contains the aadB gene cassette precisely inserted at a secondary site in the incQ plasmid RSF1010. | Q43169646 | ||
| Site-specific insertion of gene cassettes into integrons | Q43169671 | ||
| Mulundocandin, a new lipopeptide antibiotic. I. Taxonomy, fermentation, isolation and characterization | Q43459635 | ||
| L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin | Q44285427 | ||
| Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. | Q45964768 | ||
| Membrane thinning caused by magainin 2. | Q46338877 | ||
| The structure of syringomycins A1, E and G. | Q46346243 | ||
| Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes | Q47232859 | ||
| A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein | Q48044977 | ||
| Purification, characterization, and cDNA cloning of an antifungal protein from the hemolymph of Sarcophaga peregrina (flesh fly) larvae | Q48116141 | ||
| cDNA sequence analysis of an antibiotic dodecapeptide from neutrophils. | Q48144003 | ||
| Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. I. Taxonomy, production, isolation and biological activity. | Q48794436 | ||
| Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation. | Q49016487 | ||
| Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties. | Q50701437 | ||
| Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes | Q50787783 | ||
| Role of cell-binding in the antibacterial mechanism of lactoferricin B. | Q52516048 | ||
| Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. | Q52538293 | ||
| 1H-nmr studies on the structure of a new thionin from barley endosperm. | Q52546807 | ||
| Determination of the disulfide array of the first inducible antifungal peptide from insects: drosomycin from Drosophila melanogaster. | Q52550625 | ||
| Studies on the mode of action of polyoxins. VI. Effect of polyoxin B on chitin synthesis in polyoxin-sensitive and resistant strains of Alternaria kikuchiana. | Q54059295 | ||
| Yeast genes involved in growth inhibition by Pseudomonas syringae pv. syringae syringomycin family lipodepsipeptides. | Q54223508 | ||
| Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin | Q54283831 | ||
| Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents. | Q54353064 | ||
| Site-specific recombination promotes linkage between trimethoprim- and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21. | Q54379444 | ||
| In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. | Q54423329 | ||
| [Treatment of dermatomycoses with iturin] | Q74319335 | ||
| [Clinical and biological trials on iturine, a new antifungal drug.] | Q77122853 | ||
| Efficacy of syringomycin E in a murine model of vaginal candidiasis | Q77391305 | ||
| A NEW ANTIBIOTIC, POLYOXIN A | Q78521102 | ||
| Bacillomycin; an antibiotic from Bacillus subtilis active against pathogenic fungi | Q82320564 | ||
| Purification and Properties of a New Chitin-binding Antifungal CB-1 from Bacillus licheniformis | Q87662200 | ||
| Purification and antimicrobial properties of three defensins from rat neutrophils | Q35111254 | ||
| Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens | Q35112955 | ||
| Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro | Q35132244 | ||
| In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. | Q35134781 | ||
| In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates | Q35136251 | ||
| In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds | Q35137879 | ||
| Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). | Q35138759 | ||
| Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis | Q35252128 | ||
| Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations | Q35589794 | ||
| The integrons In0, In2, and In5 are defective transposon derivatives | Q35610259 | ||
| Polyoxin D inhibits growth of zoopathogenic fungi | Q35745466 | ||
| Chitin biosynthesis in Candida albicans grown in vitro and in vivo and its inhibition by nikkomycin Z. | Q35897040 | ||
| Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes | Q36443079 | ||
| Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis | Q36754062 | ||
| The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics | Q36774672 | ||
| Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins | Q36777872 | ||
| Synthesis and solution structure of the antimicrobial peptide protegrin-1. | Q36800785 | ||
| Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides | Q36807862 | ||
| Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin | Q37023162 | ||
| Activity of rabbit leukocyte peptides against Candida albicans | Q37051293 | ||
| Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity | Q37051331 | ||
| Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. | Q37734932 | ||
| Defensins | Q38146096 | ||
| Purification and cDNA cloning of an antifungal protein from the hemolymph of Holotrichia diomphalia larvae | Q38531582 | ||
| A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. | Q39780096 | ||
| Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis | Q39780220 | ||
| Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae | Q39783845 | ||
| Relative rates of transport of peptidyl drugs by Candida albicans | Q39850408 | ||
| Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits | Q39870913 | ||
| Tn21-specific structures in gram-negative bacteria from clinical isolates | Q39881818 | ||
| Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements | Q39932101 | ||
| Site-specific deletion and rearrangement of integron insert genes catalyzed by the integron DNA integrase | Q39936495 | ||
| Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related beta-lactamase transposons | Q39960818 | ||
| The significance of iron in infection | Q40330818 | ||
| Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. | Q40374058 | ||
| The region of the IncN plasmid R46 coding for resistance to beta-lactam antibiotics, streptomycin/spectinomycin and sulphonamides is closely related to antibiotic resistance segments found in IncW plasmids and in Tn21-like transposons | Q40390532 | ||
| Homology of ORFs from Tn2603 and from R46 to site-specific recombinases | Q40392152 | ||
| Studies on aculeacin. I. Isolation and characterization of aculeacin A | Q40773181 | ||
| On the mode of action of a new antifungal antibiotic, aculeacin A: Inhibition of cell wall synthesis in Saccharomyces cerevisiae | Q40773186 | ||
| Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus. | Q54557897 | ||
| Effects of synthetic form of tracheal antimicrobial peptide on respiratory pathogens. | Q54592215 | ||
| Fungicidal and binding properties of three plant peptides. | Q54711998 | ||
| Gene cassettes from the insert region of integrons are excised as covalently closed circles | Q56620567 | ||
| Fungal Membrane Responses Induced by Plant Defensins and Thionins | Q61052926 | ||
| Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae | Q61052928 | ||
| New antibiotics, trichopolyns A and B: Isolation and biological activity | Q67264810 | ||
| Studies on aculeacin. II. Isolation and characterization of aculeacins B, C, D, E, F and G | Q67576880 | ||
| Structures of aureobasidins B to R | Q67802719 | ||
| Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis | Q67836587 | ||
| Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity | Q67859428 | ||
| Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin | Q67997676 | ||
| Human neutrophil peptide defensins induce single strand DNA breaks in target cells | Q68004144 | ||
| Isolation and characterization of a 25 kDa antifungal protein from flax seeds | Q68038577 | ||
| Structure of aureobasidin A | Q68040499 | ||
| Action of iturin A, an antifungal antibiotic from Bacillus subtilis, on the yeast Saccharomyces cerevisiae: modifications of membrane permeability and lipid composition | Q68212363 | ||
| Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds | Q68225927 | ||
| Use of the chitin-synthesis inhibitor nikkomycin to treat disseminated candidiasis in mice | Q68250337 | ||
| Synthetic magainin analogues with improved antimicrobial activity | Q68486558 | ||
| Leucinostatin D, a novel peptide antibiotic from Paecilomyces marquandii | Q68962067 | ||
| Mulundocandin, a new lipopeptide antibiotic. II. Structure elucidation | Q68992559 | ||
| Leucinostatins H and K, two novel peptide antibiotics with tertiary amine-oxide terminal group from Paecilomyces marquandii isolation, structure and biological activity | Q69138279 | ||
| Synthesis of new analogs of echinocandin B by enzymatic deacylation and chemical reacylation of the echinocandin B peptide: synthesis of the antifungal agent cilofungin (LY121019) | Q69588536 | ||
| A new antibiotic, leucinostatin, derived from Penicillium lilacinum | Q69665022 | ||
| Interactions of antibiotics of the iturin group with human erythrocytes | Q70043160 | ||
| In vitro effect of phagocyte cationic peptides on Coccidioides immitis | Q70091097 | ||
| Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B | Q70239191 | ||
| Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic | Q70239217 | ||
| Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species | Q70391409 | ||
| In vitro and in vivo anti-Candida activity and toxicology of LY121019 | Q70395921 | ||
| Action of antifungal peptidolipids from Bacillus subtilis on the cell membrane of Saccharomyces cerevisiae | Q70471262 | ||
| Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase | Q70694127 | ||
| Structure of leucinostatin B, an uncoupler on mitochondria | Q71070509 | ||
| Sensitivity of fungi to nikkomycin Z | Q71088769 | ||
| Studies on peptide antibiotics, leucinostatins. I. Separation, physico-chemical properties and biological activities of leucinostatins A and B | Q71169013 | ||
| Studies on polyoxins, antifungal antibiotics. 13. The structure of polyoxins | Q71255950 | ||
| Properties of voltage-gated ion channels formed by syringomycin E in planar lipid bilayers | Q71576544 | ||
| Bacillomycin F, a new antibiotic of iturin group: isolation and characterization | Q71601741 | ||
| Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations | Q71614958 | ||
| Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. II. Physico-chemical properties and structure elucidation | Q71671909 | ||
| Molecular basis for prokaryotic specificity of magainin-induced lysis | Q72125585 | ||
| Isolation and physico-chemical characterization of an antifungal and antibacterial peptide produced by Bacillus licheniformis A12 | Q72271079 | ||
| Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic | Q72570384 | ||
| Fungicin M4: a narrow spectrum peptide antibiotic from Bacillus licheniformis M-4 | Q72723393 | ||
| Echinocandin inhibition of 1,3-β-D-glucan synthase from Candida albicans | Q72819885 | ||
| Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp | Q73172089 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | emerging pathogen | Q108429945 |
| P304 | page(s) | 1-11 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antifungal peptides: novel therapeutic compounds against emerging pathogens | |
| P478 | volume | 43 |
| Q59101171 | A broad-spectrum antimicrobial activity of Bacillus subtilis RLID 12.1 |
| Q41994258 | An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis. |
| Q34727309 | Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992-2011). |
| Q34252539 | Antibiotic resistance in the tropics. Epidemiology and surveillance of antimicrobial resistance in the tropics |
| Q39477082 | Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. |
| Q91650098 | Antifungal Peptides as Therapeutic Agents |
| Q34293126 | Antifungal proteins |
| Q26751499 | Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry |
| Q35168458 | Antimicrobial cyclic peptides for plant disease control |
| Q55982720 | Antimicrobial peptides |
| Q48091995 | Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters |
| Q94526373 | Bioactive Peptides: Synthesis, Properties, and Applications in the Packaging and Preservation of Food |
| Q34325020 | Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalis |
| Q33200348 | Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative |
| Q92707851 | Cholic Acid-Peptide Conjugates as Potent Antimicrobials against Interkingdom Polymicrobial Biofilms |
| Q36027868 | Clinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6')-Ib-cr, qnrS1 and blaSPM Genes in Brazil. |
| Q79917348 | Comparing methods for identifying Bacillus strains capable of producing the antifungal lipopeptide iturin A |
| Q54346238 | Complex class 1 integron containing bla ( CTX-M-1 ) genes isolated from Escherichia coli: a potentially novel resistant gene-capturing tool kit. |
| Q33982369 | Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model |
| Q42153897 | Costly Class-1 integrons and the domestication of the the functional integrase. |
| Q90054184 | Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
| Q64121324 | Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides |
| Q39983213 | Detection of potential risk of wastewater effluents for transmission of antibiotic resistance from Vibrio species as a reservoir in a peri-urban community in South Africa |
| Q90752535 | Early Events in Coccidioidomycosis |
| Q48163302 | Entomopathogenicity and Biological Attributes of Himalayan Treasured Fungus Ophiocordyceps sinensis (Yarsagumba). |
| Q37859396 | Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli |
| Q90563146 | Fecal Indicator Bacteria and Antibiotic Resistance Genes in Storm Runoff from Dairy Manure and Compost-Amended Vegetable Plots |
| Q35119312 | High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation |
| Q34783867 | High-throughput nano-biofilm microarray for antifungal drug discovery |
| Q33977671 | Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization |
| Q37382381 | Host immune response against Scedosporium species |
| Q38234712 | How multidrug resistance in typhoid fever affects treatment options |
| Q36094398 | Human defensins |
| Q36376608 | Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury |
| Q41390340 | Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers |
| Q36492208 | In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus |
| Q33979829 | In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically |
| Q34553406 | Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry |
| Q46043064 | Inhibitory effects of cysteine and cysteine derivatives on germination of sporangiospores and hyphal growth of different Zygomycetes |
| Q41917395 | Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori |
| Q27643174 | Lead optimization of antifungal peptides with 3D NMR structures analysis |
| Q26745953 | Melanocortin 1 Receptor: Structure, Function, and Regulation |
| Q37071179 | Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species |
| Q37875767 | Multifunctional cationic host defence peptides and their clinical applications |
| Q33742089 | Nasty Viruses, Costly Plasmids, Population Dynamics, and the Conditions for Establishing and Maintaining CRISPR-Mediated Adaptive Immunity in Bacteria |
| Q48163141 | Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds. |
| Q33982498 | Novel bifunctional inhibitor of xylanase and aspartic protease: implications for inhibition of fungal growth |
| Q37333106 | Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity |
| Q43169239 | Occurrence of integron-associated resistance gene cassettes located on antibiotic resistance plasmids isolated from a wastewater treatment plant |
| Q64056007 | On-chip manufacturing of synthetic proteins for point-of-care therapeutics |
| Q28547573 | Oviduct-specific expression of human neutrophil defensin 4 in lentivirally generated transgenic chickens |
| Q36870098 | Peeping into genomic architecture by re-sequencing of Ochrobactrum intermedium M86 strain during laboratory adapted conditions |
| Q36538861 | Peptide antimicrobial agents |
| Q33739003 | Pharmacokinetic characteristics of caspofungin in two pediatric liver transplant patients |
| Q22121986 | Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria |
| Q33849225 | Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism |
| Q50001707 | Prevalence and characterization of class 1 integrons in multi-drug resistant Salmonella sp. from China in 2010. |
| Q34980196 | Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan. |
| Q38802524 | Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools |
| Q37875765 | Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action |
| Q33484091 | Sporicidal activity of synthetic antifungal undecapeptides and control of Penicillium rot of apples |
| Q61812764 | Structure and Synthesis of Antifungal Disulfide β-Strand Proteins from Filamentous Fungi |
| Q31136813 | Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance |
| Q34177095 | Symbiotic plant peptides eliminate Candida albicans both in vitro and in an epithelial infection model and inhibit the proliferation of immortalized human cells. |
| Q92988294 | Systematical Analysis of the Protein Targets of Lactoferricin B and Histatin-5 Using Yeast Proteome Microarrays |
| Q50131973 | The Plant Defensin NaD1 Enters the Cytoplasm of Candida Albicans via Endocytosis |
| Q39740573 | The antifungal protein from Aspergillus giganteus causes membrane permeabilization |
| Q89879149 | The interaction Between Carbohydrates and the Antimicrobial Peptide P-113Tri is Involved in the Killing of Candida albicans |
| Q47160311 | Transgenic expression of antimicrobial peptide D2A21 confers resistance to diseases incited by Pseudomonas syringae pv. tabaci and Xanthomonas citri, but not Candidatus Liberibacter asiaticus. |
| Q35127593 | Ultrashort antibacterial and antifungal lipopeptides |
| Q64987903 | Water-soluble exudates from seeds of Kochia scoparia exhibit antifungal activity against Colletotrichum graminicola. |
| Q57789682 | and Assessment of FK506 Analogs as Novel Antifungal Drug Candidates |
Search more.